Browse Drug Recalls
24 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 24 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 24 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Oct 2, 2023 | Tropi-Phen (Tropicamide 1% phenylephrine HCl 2.5%) ophthalmic solution, 15 mL... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Foscarnet Sodium 2.4mg/0.1 mL solution for injection, 0.2 mL single-dose Sta... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Endophth Kit (Vancomycin 1mg/0.1 mL - Ceftazidime 2.25mg/0.1 mL), Rx only, Co... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, C... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Tropi-Phen (tropicamide 1%, phenylephrine 2.5%) ophthalmic solution, 5mL mult... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Vancomycin 1 MG/0.1 ML Solution for Intraocular Injection, 0.8 ML Single Dose... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Calcium Gluconate 2.5% solution for inhalation, 5mL pre-filled syringes, Rx o... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal adminis... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Calcium Gluconate Ophthalmic Irrigation Solution 1%, 500 mL bags, Rx only, C... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | TPC Drops (tropicamide 1%- phenylephrine 2.5%- cyclopentolate HCl 1% ophthalm... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 6... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Lidocaine HCl 4% ophthalmic solution, 3 mL single-use dropper, Rx only, Compo... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Calcium chloride Solution for Intravenous Injection, 20 mg/mL, 500 mL bags, R... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL s... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Cefuroxime 4mg /0.4 mL (10 mg/mL), 1mL syringe, Rx only, Compounded by: Pine ... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Oct 2, 2023 | Lidocaine-phenylephrine 1%-1.5% 1mL Single Dose Vial, Rx only, Compounded by ... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Mar 27, 2023 | Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip ... | Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect. | Class III | Pine Pharmaceuticals, LLC |
| Dec 22, 2022 | Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular In... | CGMP Deviations: Raw material recalled by repackager, due to discoloration. | Class II | Pine Pharmaceuticals, LLC |
| Jul 27, 2022 | Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar ... | Lack of Assurance of Sterility | Class II | Pine Pharmaceuticals, LLC |
| Mar 5, 2018 | Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded ... | Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which con... | Class III | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe f... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal inje... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.